Bao Pharma-B (02659) announced interim results: 截至2026年6月30日止六個月中期業績公告, net profit attributable to owners RMB-1.5bn Title: 截至2026年6月30日止六個月中期業績公告 Revenue: RMB9.9M Net profit: RMB-1.5bn Profit attributable to owners: RMB-1.5bn
